These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 26876867)
1. Spontaneous arrangement of a tumor targeting hyaluronic acid shell on irinotecan loaded PLGA nanoparticles. Giarra S; Serri C; Russo L; Zeppetelli S; De Rosa G; Borzacchiello A; Biondi M; Ambrosio L; Mayol L Carbohydr Polym; 2016 Apr; 140():400-7. PubMed ID: 26876867 [TBL] [Abstract][Full Text] [Related]
2. Development and mechanistic insight into enhanced cytotoxic potential of hyaluronic acid conjugated nanoparticles in CD44 overexpressing cancer cells. Saneja A; Nayak D; Srinivas M; Kumar A; Khare V; Katoch A; Goswami A; Vishwakarma RA; Sawant SD; Gupta PN Eur J Pharm Sci; 2017 Jan; 97():79-91. PubMed ID: 27989859 [TBL] [Abstract][Full Text] [Related]
3. Hyaluronic acid-decorated poly(lactic-co-glycolic acid) nanoparticles for combined delivery of docetaxel and tanespimycin. Pradhan R; Ramasamy T; Choi JY; Kim JH; Poudel BK; Tak JW; Nukolova N; Choi HG; Yong CS; Kim JO Carbohydr Polym; 2015 Jun; 123():313-23. PubMed ID: 25843864 [TBL] [Abstract][Full Text] [Related]
4. Targeted and controlled drug delivery system loading artersunate for effective chemotherapy on CD44 overexpressing cancer cells. Tran TH; Nguyen TD; Van Nguyen H; Nguyen HT; Kim JO; Yong CS; Nguyen CN Arch Pharm Res; 2016 May; 39(5):687-94. PubMed ID: 27015824 [TBL] [Abstract][Full Text] [Related]
5. Biodegradable nanoparticles sequentially decorated with Polyethyleneimine and Hyaluronan for the targeted delivery of docetaxel to airway cancer cells. Maiolino S; Russo A; Pagliara V; Conte C; Ungaro F; Russo G; Quaglia F J Nanobiotechnology; 2015 Apr; 13():29. PubMed ID: 25888948 [TBL] [Abstract][Full Text] [Related]
6. Development of poly(lactic-co-glycolic) acid nanoparticles-embedded hyaluronic acid-ceramide-based nanostructure for tumor-targeted drug delivery. Park JH; Lee JY; Termsarasab U; Yoon IS; Ko SH; Shim JS; Cho HJ; Kim DD Int J Pharm; 2014 Oct; 473(1-2):426-33. PubMed ID: 25079433 [TBL] [Abstract][Full Text] [Related]
7. Hyaluronic acid-decorated dual responsive nanoparticles of Pluronic F127, PLGA, and chitosan for targeted co-delivery of doxorubicin and irinotecan to eliminate cancer stem-like cells. Wang H; Agarwal P; Zhao S; Xu RX; Yu J; Lu X; He X Biomaterials; 2015 Dec; 72():74-89. PubMed ID: 26344365 [TBL] [Abstract][Full Text] [Related]
8. Hyaluronic acid-decorated PLGA-PEG nanoparticles for targeted delivery of SN-38 to ovarian cancer. Vangara KK; Liu JL; Palakurthi S Anticancer Res; 2013 Jun; 33(6):2425-34. PubMed ID: 23749891 [TBL] [Abstract][Full Text] [Related]
9. Hyaluronic acid-grafted PLGA nanoparticles for the sustained delivery of berberine chloride for an efficient suppression of Ehrlich ascites tumors. Bhatnagar P; Kumari M; Pahuja R; Pant AB; Shukla Y; Kumar P; Gupta KC Drug Deliv Transl Res; 2018 Jun; 8(3):565-579. PubMed ID: 29441466 [TBL] [Abstract][Full Text] [Related]
10. Self-assembled nanoparticles of hyaluronic acid/poly(DL-lactide-co-glycolide) block copolymer. Jeong YI; Kim DH; Chung CW; Yoo JJ; Choi KH; Kim CH; Ha SH; Kang DH Colloids Surf B Biointerfaces; 2012 Feb; 90():28-35. PubMed ID: 22001557 [TBL] [Abstract][Full Text] [Related]
11. Irinotecan and 5-fluorouracil-co-loaded, hyaluronic acid-modified layer-by-layer nanoparticles for targeted gastric carcinoma therapy. Gao Z; Li Z; Yan J; Wang P Drug Des Devel Ther; 2017; 11():2595-2604. PubMed ID: 28919710 [TBL] [Abstract][Full Text] [Related]
12. SN38 polymeric nanoparticles: in vitro cytotoxicity and in vivo antitumor efficacy in xenograft balb/c model with breast cancer versus irinotecan. Sepehri N; Rouhani H; Tavassolian F; Montazeri H; Khoshayand MR; Ghahremani MH; Ostad SN; Atyabi F; Dinarvand R Int J Pharm; 2014 Aug; 471(1-2):485-97. PubMed ID: 24879937 [TBL] [Abstract][Full Text] [Related]
13. CD44 targeted chemotherapy for co-eradication of breast cancer stem cells and cancer cells using polymeric nanoparticles of salinomycin and paclitaxel. Muntimadugu E; Kumar R; Saladi S; Rafeeqi TA; Khan W Colloids Surf B Biointerfaces; 2016 Jul; 143():532-546. PubMed ID: 27045981 [TBL] [Abstract][Full Text] [Related]
14. Development and characterization of hyaluronic acid modified PLGA based nanoparticles for improved efficacy of cisplatin in solid tumor. Alam N; Koul M; Mintoo MJ; Khare V; Gupta R; Rawat N; Sharma PR; Singh SK; Mondhe DM; Gupta PN Biomed Pharmacother; 2017 Nov; 95():856-864. PubMed ID: 28903181 [TBL] [Abstract][Full Text] [Related]
15. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin. Yadav AK; Mishra P; Mishra AK; Mishra P; Jain S; Agrawal GP Nanomedicine; 2007 Dec; 3(4):246-57. PubMed ID: 18068091 [TBL] [Abstract][Full Text] [Related]
16. TPGS2k/PLGA nanoparticles for overcoming multidrug resistance by interfering mitochondria of human alveolar adenocarcinoma cells. Wang DF; Rong WT; Lu Y; Hou J; Qi SS; Xiao Q; Zhang J; You J; Yu SQ; Xu Q ACS Appl Mater Interfaces; 2015 Feb; 7(7):3888-901. PubMed ID: 25644220 [TBL] [Abstract][Full Text] [Related]
17. Biodegradable self-assembled nanoparticles of poly (D,L-lactide-co-glycolide)/hyaluronic acid block copolymers for target delivery of docetaxel to breast cancer. Huang J; Zhang H; Yu Y; Chen Y; Wang D; Zhang G; Zhou G; Liu J; Sun Z; Sun D; Lu Y; Zhong Y Biomaterials; 2014 Jan; 35(1):550-66. PubMed ID: 24135268 [TBL] [Abstract][Full Text] [Related]
18. Formulation and evaluation of tacrolimus-loaded galactosylated Poly(lactic-co-glycolic acid) nanoparticles for liver targeting. Mistry NP; Desai JL; Thakkar HP J Pharm Pharmacol; 2015 Oct; 67(10):1337-48. PubMed ID: 25944126 [TBL] [Abstract][Full Text] [Related]
19. Mechanisms of chitosan-coated poly(lactic-co-glycolic acid) nanoparticles for improving oral absorption of 7-ethyl-10-hydroxycamptothecin. Guo M; Rong WT; Hou J; Wang DF; Lu Y; Wang Y; Yu SQ; Xu Q Nanotechnology; 2013 Jun; 24(24):245101. PubMed ID: 23702815 [TBL] [Abstract][Full Text] [Related]
20. Poly aspartic acid peptide-linked PLGA based nanoscale particles: potential for bone-targeting drug delivery applications. Jiang T; Yu X; Carbone EJ; Nelson C; Kan HM; Lo KW Int J Pharm; 2014 Nov; 475(1-2):547-57. PubMed ID: 25194353 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]